People with cystic fibrosis are susceptible to a range of bacterial and fungal infections which can reduce lung function and, ultimately, reduce life expectancy.
In order to stay as infection-free as possible, people with cystic fibrosis (CF) receive regular courses of intravenous antibiotics, usually delivered in hospital.
However, the rise in infections that are resistant to antibiotics, such as MRSA, and ongoing problems with bacteria such as Burkholderia cepacia complex, Pseudomonas aeruginosa and Mycobacterium abscessus means that more and better antibiotics are needed. Find out more about how cystic fibrosis affects the lungs and how the risk of passing lung infections from one person to another (cross-infection) affects people with the condition.
We continue to fund research aimed at understanding these bacteria and other micro-organisms and finding better ways to fight them.
Read more about the projects below:
Strategic Research Centre 1 - Led by Professor Jane Davies
Strategic Research Centre 3 - Led by Professor Andres Floto
Research we fund
We fund research to tackle some of the most pressing issues in CF today. Find out how your donations are making a difference.
What is CF?
Cystic fibrosis, or CF, affects the lungs, digestive system and other organs, and there are over 10,600 people living with it in the UK.
Get in touch with us to speak to someone on our Helpline, find out about an event or speak to our Press Team.